Reports Q1 revenue $47.2M, consensus $49.8M.”It’s an incredible time to be at LifeVantage (LFVN) as we just launched the MindBody GLP-1 System(TM), an amazing innovation targeting consumers searching for an effective, sustainable weight management solution. This product, launched on October 11th, significantly expands our total addressable market and the initial response from our independent Consultants and customers has been overwhelming,” said Steve Fife, President and CEO of LifeVantage. “In the first quarter, we again delivered solid profitability metrics despite lower revenues, including an increase of 11% in Adjusted EBITDA and a 160 basis point improvement in Adjusted EBITDA margin. We continue to focus on optimizing our cost structure while also being strategic with our investments in growth and innovation. Combined with our strong balance sheet, we remain well positioned to deliver future growth and significant long-term value for stockholders.”
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- LFVN Earnings this Week: How Will it Perform?
- LifeVantage announces U.S. launch of MindBody GLP-1 System
- LifeVantage announces update to evolve compensation plan with new sharing bonus
- LifeVantage completes human clinical trial with new GLP-1 system
- LifeVantage announces in vitro results for new GLP-1 system